Lipocine (NASDAQ:LPCN) Stock Crosses Above 50 Day Moving Average of $6.95

Lipocine Inc. (NASDAQ:LPCNGet Free Report) shares crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $6.95 and traded as high as $7.72. Lipocine shares last traded at $7.72, with a volume of 19,272 shares traded.

Analyst Ratings Changes

Separately, StockNews.com began coverage on shares of Lipocine in a research report on Monday, May 13th. They set a “hold” rating on the stock.

Check Out Our Latest Report on Lipocine

Lipocine Stock Up 3.8 %

The stock has a market capitalization of $41.29 million, a price-to-earnings ratio of -4.51 and a beta of 1.12. The business’s 50-day moving average is $6.95 and its two-hundred day moving average is $5.13.

Lipocine (NASDAQ:LPCNGet Free Report) last posted its quarterly earnings results on Thursday, May 9th. The specialty pharmaceutical company reported $0.66 earnings per share for the quarter. The business had revenue of $7.62 million for the quarter. As a group, analysts forecast that Lipocine Inc. will post -1 EPS for the current fiscal year.

Lipocine Company Profile

(Get Free Report)

Lipocine Inc, a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs for the treatment of central nervous system (CNS) disorders. Its lead product candidate is TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate.

See Also

Receive News & Ratings for Lipocine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lipocine and related companies with MarketBeat.com's FREE daily email newsletter.